Related Experiment Videos
Impact of CardioMEMS device placement on lifestyle modifications: a "pseudo-placebo" effect beyond the expected?
Mahmoud Assaad1,2, Robby Singh1,2, Sinan Sarsam1,2
11 Providence Hospital/Michigan State University, Southfield, MI, USA.
Insights
The CardioMEMS device improved heart failure patients' quality of life. Patients also adopted healthier lifestyles, including better diets and increased physical activity, following device implantation.
Area of Science:
- Cardiology
- Medical Devices
Background:
- Congestive heart failure (CHF) is a major cause of death and healthcare costs in the US.
- The CHAMPION trial demonstrated benefits of the CardioMEMS device for CHF patients, including reduced hospitalizations and improved quality of life.
Purpose of the Study:
- To investigate the "pseudo-placebo" effect of CardioMEMS device implantation on patient lifestyle modifications.
- To assess changes in diet, physical activity, and medication adherence post-implantation.
Main Methods:
- A follow-up survey was conducted with 30 patients implanted with the CardioMEMS device.
- Survey questions focused on lifestyle changes, symptom improvement, and medication regimen adjustments.
Main Results:
- 57% of patients reported improved dyspnea.
- 70% of patients improved their diet, and 43% increased physical activity.
- Data transmission from the device was difficult for only 7% of patients.
Conclusions:
- CardioMEMS device implantation not only offers clinical benefits but also appears to motivate patients towards positive lifestyle changes.
- This "pseudo-placebo" effect contributes to overall patient well-being and management of heart failure.
Abstract:
Introduction Congestive heart failure is a leading cause of cardiovascular mortality and morbidity in the United States and places a significant economic burden on the health care system. The CHAMPION trial showed significant reductions in heart failure hospitalizations and length of stay as well as improvements in quality of life among patients who underwent implantation of the CardioMEMS device (CardioMEMS Inc., Atlanta, GA, USA). While the benefits of the device have been well demonstrated, we explored the "pseudo-placebo" effect of device placement on patients' lifestyle modifications. Methods Thirty patients with the CardioMEMS device were contacted for a follow-up survey that included questions about lifestyle modifications, symptomatic and dietary improvement, increased physical activity, and changes in their cardiac medication regimen. Results Dyspnea improved in 57% of patients, 70% of patients improved their diet, and 43% increased their physical activity. Only 7% of patients found it difficult to transmit the data. Discussion The CHAMPION trial showed numerous benefits for patients who underwent CardioMEMS device placement. In our study, we found that device placement also resulted in a "pseudo-placebo" effect with most patients making positive lifestyle modifications.